Amylin Pharmaceuticals Appoints Theodore Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer SAN DIEGO, / - / -- Amylin Pharmaceuticals, Inc. Mihalik has extensive previous experience in diabetes and has a successful track record in leadership at a number of companies focused on improving care. Mihalik brings more than 30 years of experience across multiple commercial roles, including global product development, sales and sales management, product launches and brand management. AMLN) announced today that Roderick P.

Mihalik has been appointed Senior Vice President, Sales and Marketing and Chief Commercial Officer.

Mihalik was Business Unit Head of Diabetes Care for Marci U.S., where he was responsible for the launch, sales and marketing for Actos(R) (pioglitazone), insulin injection pens (Humulin(R), Humalog(R)) and the preparation for the launch of Cialis(R) (tadalafil) in the U.S. Mihalik was Vice President of Global Brand Development Diabetes and Endocrine Platform Team Leader at Eli Lenka and Company, where he managed the second largest therapeutic area for the company and was responsible for product development beyond Phase 2b to launch for lifecycle planning and commercialization.

His career has focused on diabetes, with numerous leadership roles at leading pharmaceutical companies.